Showing results (6221-6230 of 10,080) with videos related to
Sort By:
Pageof 1,008
Current Pharmaceutical Design|November 17, 2004
Acetylcholinesterase inhibitors as a starting point towards improved Alzheimer's disease therapeuticsMaurizio Recanatini, Piero ValentiCurrent Pharmaceutical Design|November 17, 2004
New classes of AChE inhibitors with additional pharmacological effects of interest for the treatment of Alzheimer's diseaseM Villarroya, A G García, J L MarcoCurrent Pharmaceutical Design|November 17, 2004
Predictive in vitro models of the sterilizing activity of anti-tuberculosis drugsDenis A Mitchison, Anthony R M CoatesCurrent Pharmaceutical Design|November 17, 2004
Angiotensin and bradykinin: targets for the treatment of vascular and neuro-glial pathology in diabetic retinopathyJennifer L Wilkinson-Berka, Erica L FletcherCurrent Pharmaceutical Design|December 8, 2004
Virus attachment and entry offer numerous targets for antiviral therapyRalf AltmeyerCurrent Pharmaceutical Design|December 8, 2004
Coumarin and isocoumarin as serine protease inhibitorsLionel Pochet, Raphaël Frédérick, Bernard MasereelCurrent Pharmaceutical Design|December 8, 2004
Mollusk-derived growth factor and the new subfamily of adenosine deaminase-related growth factorsD-B G Akalal, C H Schein, G T NagleCurrent Pharmaceutical Design|December 8, 2004
Action of anti-HIV drugs and resistance: reverse transcriptase inhibitors and protease inhibitorsTomozumi ImamichiCurrent Pharmaceutical Design|January 11, 2005
Advances in therapy for psoriasis: an overview of infliximab, etanercept, efalizumab, alefacept, adalimumab, tazarotene, and pimecrolimusRitu Saini, William D Tutrone, Jeffrey M WeinbergCurrent Pharmaceutical Design|February 23, 2005
Docking: successes and challengesVenkatraman Mohan, Alan C Gibbs, Maxwell D Cummings, et al.Pageof 1,008